Publications

A new antihistamine levocetirizine inhibits eosinophil adhesion to vascular cell adhesion molecule-1 under flow conditions Page_white_acrobat 218 KB Wu P., Mitchell S., Walsh G.M. (2005). Clin. Exp. Allergy 2005; 35:1073–1079.

A multidisciplinary approach to the study of T cell migration Page_white_acrobat 447 KB Long A., Mitchell S., Kashanin D., Williams V., Prina Mello A., Shvets I., Kelleher D., Volkov Y. Ann. N. Y. Sci. 1028: 313-319 (2004).

Microfluidics Enabling Platform for Cell-based Assays Page_white_acrobat 648 KB Williams V., Kashanin D., Shvets I.V., Mitchell S., Volkov Y., Kelleher D. JALA Vol. 7, No. 6, December 2002.

Immunomodulation: Are Statins True "Wonder Drugs"? Page_white_acrobat 788 KB Fitzgerald K., Lowes D.; Screening Trends for Drug Discovery, Issue 4, 2007

Microfluidics: in search of a killer application Page_white_acrobat 329 KB Nathan Blow Nature Methods - 4, 665 - 670 (2007)

Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT1R antagonism Page_white_acrobat 264 KB Robinson A. J., Kashanin D., O'Dowd F., Williams V., Walsh G. M., Journal of Leukocyte Biology Volume 83, June 2008

Mechanisms of Metastasis - Cellix's VenaFlux Platform Pursues Metatstatic Movement Page_white_acrobat 164 KB Fitzgerald K., Rafferty M., Gremel G., Gallagher W.; Screening Trends for Drug Discovery, Issue 2, 2008

Download Adobe Acrobat Reader to view .pdfs

Cellix Ltd, Unit 381, Institute of Molecular Medicine, Trinity Centre for Health Sciences,
James's Street, Dublin 8, Ireland.

Tel: +353-1-896-4016     Fax: +353-1-896-2771     Email: